NG
PFE icon

NWK Group’s Pfizer PFE Stock Holding History

NWK Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,500
Closed -$91K – 143
2021
Q1 		$91K Hold
2,500
– – 0.04% 80
2020
Q4 		$92K Sell
2,500
-135
-5% -$4.95K 0.04% 76
2020
Q3 		$92K Sell
2,635
-324
-11% -$11.4K 0.05% 75
2020
Q2 		$92K Buy
2,959
+324
+12% +$11K 0.05% 70
2020
Q1 		$82K Sell
2,635
-586
-18% -$20K 0.07% 67
2019
Q4 		$120K Buy
+3,221
New +$115K 0.1% 71

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

NWK Group's PFE Position: Q2 2021 in Review

NWK Group sold out of Pfizer (PFE) in Q2 2021, closing a stake of 2,500 shares — an estimated $91K sold.

NWK Group first reported a position in PFE in Q4 2019 and held it in 6 quarters. The position peaked at $120K in Q4 2019. 2,732 funds tracked by Wall St. Rank hold PFE as of Q2 2021.

  • NWK Group reported no remaining Pfizer position as of Q2 2021 after selling out during the quarter.
  • NWK Group sold 2,500 Pfizer shares in Q2 2021, an estimated $91K.
  • NWK Group first reported a position in Pfizer in Q4 2019 and held it in 6 quarters.
  • NWK Group's Pfizer position peaked at $120K in Q4 2019.
  • 2,732 funds tracked by Wall St. Rank held Pfizer as of Q2 2021.

Based on NWK Group's 13F filing for Q2 2021, filed 16 Aug 2021.